Prospective Study on Patients With Obstructive Sleep Apnea in Hong Kong (PrOSA)
NCT ID: NCT04659291
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2020-08-30
2028-08-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Obstructive Sleep Apnea (OSA) and the Association With Cognitive Impairment
NCT04658290
Continuous Positive Airway Pressure Use in Asthma With Moderate to Severe Obstructive Sleep Apnea Patients
NCT01383564
Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance
NCT02085720
A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
NCT00843583
Evaluation of New Diagnostic and Treatment Algorithm for Obstructive Sleep Apnea
NCT00425659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18 or above
* must be able to speak, read and understand Chinese or English
* possess the ability to respond to questions and follow instructions.
Exclusion Criteria
* a limited life expectancy due to illness unrelated to sleep apnea
* human immunodeficiency virus (HIV),
* advanced renal disease,
* uncontrolled malignancies
* documented alcohol or drug abuse up to 1 year prior to inclusion in the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susanna SS Ng
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese University of Hong
Hong Kong, Please Select, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PrOSA study/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.